NCT03746431 2026-01-07A Phase 1 Study of [225Ac]-FPI-1434 InjectionFusion Pharmaceuticals Inc.Phase 1 Terminated78 enrolled
NCT03145909 2018-11-29A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)AbbViePhase 1 Terminated19 enrolled
NCT01832974 2015-04-27Possible New Therapy for Advanced CancerINSYS Therapeutics IncPhase 1 Terminated9 enrolled